Gut microbiota and ischemic stroke: The role of trimethylamine n-oxide
As of April 2026, the BPC-157 FDA approval status remains what it has been for the last two decades: no finished-drug approval, no active Investigational New Drug (IND) application, and no FDA-registered human clinical trials
Many do not, because the compound quality is unverified, the dose is based on internet research rather than clinical assessment, and there is no baseline, no follow-up, and no protocol adjustment based on individual response
All post-2001 mechanistic discussion in review articles is derivative of the original Novo Nordisk-authored papers
Our formula is vegetarian (not vegan), and contains dairy (lactoferrin) and tree nuts (almond oil).